Literature DB >> 3931772

Rheumatoid factors and amyloidosis in rheumatoid arthritis.

C P Maury, A M Teppo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3931772      PMCID： PMC1416925          DOI： 10.1136/bmj.291.6501.1015

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

Review 1.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

2.  Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome.

Authors:  A T Masi; J A Maldonado-Cocco; S B Kaplan; S L Feigenbaum; R W Chandler
Journal:  Semin Arthritis Rheum       Date:  1976-05       Impact factor: 5.532

3.  Is uremia immunosuppressive in renal transplantation?

Authors:  P Häyry; E von Willebrand; E Taskinen; K Höckerstedt; J Ahonen; B Eklund
Journal:  Transplantation       Date:  1982-11       Impact factor: 4.939

4.  IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity.

Authors:  R Wernick; P Merryman; I Jaffe; M Ziff
Journal:  Arthritis Rheum       Date:  1983-05

5.  Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.

Authors:  J S Dixon; M E Pickup; J R Lowe; C Hallett; M R Lee; V Wright
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103
  5 in total
  5 in total

1.  HLA typing and seropositivity in Finnish and in Polish patients with rheumatoid arthritis and amyloidosis.

Authors:  S Tiitinen; K Kaarela; A Filipowicz-Sosnowska; B Maczynska-Rusiniak; K Lehtinen; M Leirisalo-Repo; L Paimela; S Koskimies
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

2.  Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics.

Authors:  T M El Mansoury; B P C Hazenberg; S A El Badawy; A H Ahmed; J Bijzet; P C Limburg; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

3.  Antibodies to amyloid A protein in rheumatic diseases.

Authors:  C P Maury; A M Teppo
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

4.  Enzyme immunoassay of complement-binding rheumatoid factors.

Authors:  A M Teppo; C P Maury
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

5.  Rheumatoid factor in rheumatoid arthritis associated renal disease and in lupus nephritis.

Authors:  H Helin; M Korpela; J Mustonen; A Pasternack
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.